As shown in Table 1, in TP53 truncating mutation cancers, such as BRCA, HNSC, LIHC, LUAD, LUSC, SKCM, PAAD, SARC, and STAD, TP53 was significantly positively correlated with the immune score, as well as stromal score and estimate score, while it was negatively correlated with UCS. Here, TP53 is linked to cancer.